<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="117081-2018"
            EDITION="2018053">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-120195-001</RECEPTION_ID>
      <DELETION_DATE>20180622</DELETION_DATE>
      <FORM_LG_LIST>NL </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>53</NO_OJ>
         <DATE_PUB>20180316</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 053-117081</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="NL">http://ted.europa.eu/udl?uri=TED:NOTICE:117081-2018:TEXT:NL:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>NL</LG_ORIG>
         <ISO_COUNTRY VALUE="BE"/>
         <IA_URL_GENERAL>www.stlucas.be</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="BE251">Arr. Brugge</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="BE251">Arr. Brugge</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="BE">BELGIQUE-BELGIË</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="EUR">1919651.76</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 057-106673</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180314</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Бeлгия</TI_CY>
            <TI_TOWN>Брюж</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Belgie</TI_CY>
            <TI_TOWN>Bruggy</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Brügge</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Βέλγιο</TI_CY>
            <TI_TOWN>Μπρυζ</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Belgium</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Bélgica</TI_CY>
            <TI_TOWN>Brujas</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Belgique</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Bheilg, an</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Belgium</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Belgio</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Briugė</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Beļģija</TI_CY>
            <TI_TOWN>Brige</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>il-Belġju</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>België</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Brugia</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Bélgica</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Belgia</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Belgicko</TI_CY>
            <TI_TOWN>Bruggy</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Belgija</TI_CY>
            <TI_TOWN>Bruges</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Belgien</TI_CY>
            <TI_TOWN>Brugge</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="NL">AZ Sint-Lucas Brugge vzw</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="NL">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>AZ Sint-Lucas Brugge vzw</OFFICIALNAME>
               <ADDRESS>Sint-Lucaslaan 29</ADDRESS>
               <TOWN>Brugge</TOWN>
               <POSTAL_CODE>8310</POSTAL_CODE>
               <COUNTRY VALUE="BE"/>
               <CONTACT_POINT>Mevrouw Nina Porwolik</CONTACT_POINT>
               <PHONE>+32 50365430</PHONE>
               <E_MAIL>Nina.Porwolik@stlucas.be</E_MAIL>
               <FAX>+32 50365426</FAX>
               <n2016:NUTS CODE="BE251"/>
               <URL_GENERAL>www.stlucas.be</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE_OTHER>Ziekenhuis</CA_TYPE_OTHER>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Raamovereenkomst INFLIXIMAB</P>
            </TITLE>
            <REFERENCE_NUMBER>2017/008/npor</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Zie II.2.4.</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="EUR">1919651.76</VAL_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="BE251"/>
               <MAIN_SITE>
                  <P>Apotheek, AZ Sint-Lucas Brugge vzw, Sint-Lucaslaan 29 te 8310 Brugge.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>Deze gunning betreft de levering van Infliximab voor een periode van 2 jaar. Deze gaat ten vroegste in op 01/07/2017 en kan 2 keer met 1 jaar verlengd worden.</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Niet gespecifieerd</AC_CRITERION>
                  <AC_WEIGHTING>Niet gespecifieerd</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_PRICE>
                  <AC_WEIGHTING>Niet gespecifieerd</AC_WEIGHTING>
               </AC_PRICE>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 057-106673</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>2017/008/npor</CONTRACT_NO>
            <LOT_NO>1</LOT_NO>
            <TITLE>
               <P>Raamovereenkomst INFLIXIMAB</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-05</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>3</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_OTHER_EU>0</NB_TENDERS_RECEIVED_OTHER_EU>
               <NB_TENDERS_RECEIVED_NON_EU>0</NB_TENDERS_RECEIVED_NON_EU>
               <NB_TENDERS_RECEIVED_EMEANS>0</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>MUNDIPHARMA COMM.VA</OFFICIALNAME>
                     <ADDRESS>Blarenberglaan 3C</ADDRESS>
                     <TOWN>Mechelen</TOWN>
                     <POSTAL_CODE>2800</POSTAL_CODE>
                     <COUNTRY VALUE="BE"/>
                     <PHONE>+32 15451180</PHONE>
                     <FAX>+32 15451190</FAX>
                     <n2016:NUTS CODE="BE"/>
                  </ADDRESS_CONTRACTOR>
                  <NO_SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="EUR">1919651.76</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Zie bestek.</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Rechtbank van Eerste Aanleg</OFFICIALNAME>
               <ADDRESS>Kazernevest 3</ADDRESS>
               <TOWN>Brugge</TOWN>
               <POSTAL_CODE>8000</POSTAL_CODE>
               <COUNTRY VALUE="BE"/>
            </ADDRESS_REVIEW_BODY>
            <REVIEW_PROCEDURE>
               <P>Overeenkomstig artikel 14 van de wet van 17 juni 2013 betreffende de motivering, de informatie en de rechtsmiddelen inzake overheidsopdrachten en bepaalde opdrachten voor werken, leveringen en diensten, kan u tevens opteren om een vordering tot nietigverklaring van deze beslissing in te stellen. Dit gebeurt door middel van dagvaarding voor de rechtbank van eerste aanleg West-Vlaanderen, afdeling Brugge. Dit beroep moet op straffe van onontvankelijkheid worden ingediend binnen de 60 dagen, vanaf de dag volgend op de verzenddatum van deze brief.</P>
            </REVIEW_PROCEDURE>
            <DATE_DISPATCH_NOTICE>2018-03-14</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
